Jump to content


Member Since 21 January 2012 - 01:48 AM
Offline Last Active Nov 24 2020 06:11 AM

Posts I've Made

In Topic: Coronavirus

23 November 2020 - 06:41 PM

View PostLFC, on 23 November 2020 - 04:37 PM, said:

Texass governor Abbott is dug in on needlessly killing state residents.

Paving the way to a blue Texas?

In Topic: The Bird Thread (was One for LFC)

23 November 2020 - 01:41 PM

It's a Hitch-Hiking Owl.

In Topic: The Lincoln Project and Other “Republican Turncoat” Advertisers

23 November 2020 - 10:27 AM

Lincoln Project: Remove Republic From Republican

In Topic: Republican Party has ‘flat out lost its mind’

23 November 2020 - 09:56 AM

Posted Image

In Topic: Coronavirus

23 November 2020 - 08:34 AM

Another COVID-19 vaccine candidate may also prevent further coronavirus transmission.


A third COVID-19 vaccine candidate has convincing evidence that it works, and it may be easier to distribute and cheaper than the two other vaccines already shown to protect people. Developed by the company AstraZeneca in partnership with the University of Oxford, the vaccine had an average efficacy of 70% in preventing the disease, the developers announce today in press releases. In one dosing scheme its efficacy was 90%, according to results from the interim analysis of clinical trial data.

AstraZeneca says about three billion doses of the vaccine could be ready in 2021. Whereas the apparently powerful COVID-19 vaccines recently announced by Moderna and the Pfizer/BioNTech collaboration rely on a snippet of messenger RNA coding for the spike surface protein of SARS-CoV-2, the AstraZeneca/Oxford vaccine stimulates immunity by using a crippled chimpanzee adenovirus as a “vector” to deliver the gene for spike. (A Russian team has also presented evidence its vaccine works but noted too few COVID-19 cases at the time to persuade many outside scientists.)